Ledger.Open graph →
SEC Form D · filed October 2, 2025

Ansa Biotechnologies, Inc

Offering
$55.5M
Sold
$45.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Daniel T. Lin-Arlow · Emeryville, CAExec · DirectorJason T. Gammack · Emeryville, CAExec · DirectorChenny T. Zhang · Emeryville, CADirectorMatthew T. Mcmanus · Emeryville, CADirectorSebastian T. Palluk · Emeryville, CAExecYanniv T. Dorone · Emeryville, CADirectorJason T. Gammack · Emeryville, CAExec · DirectorMatthew T. Mcmanus · Emeryville, CADirectorYmir Vigfusson · DOVER, DEExecYanniv T. Dorone · Emeryville, CADirectorChenny T. Zhang · Emeryville, CADirectorRichard Chesney · Dallas, TXExec · DirectorNewton Howard · FRISCO, TXExec · DirectorRobert V. Delaney, Jr · New York, NYExecMichael E. West · New York, NYExec · DirectorAndreh Kalatizadeh · Kew Gardens, NYDirectorAlen Kalati · Springfield, NJDirectorDavid Benhaim · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗